Please login to view this media
- Talk
- USA
Preoperative Opioid Prescription is an Independent Risk Factor for Complication and Increased Healthcare Utilization Following Total Shoulder Arthroplasty
Description
In this presentation, Corey Spencer discusses the impact of preoperative opioid use on outcomes for patients undergoing primary total shoulder arthroplasty. Highlighting the trend of increasing total shoulder surgeries over the years, he addresses the growing opioid epidemic and its effects on orthopedic patients. The study aims to investigate whether preoperative opioid use leads to higher complications, increased healthcare costs, and more frequent revision surgeries, particularly noting that findings from hip and knee arthroplasties suggest such detrimental outcomes.
The analysis involved nearly 30,000 patients, revealing startling statistics: 44% were prescribed preoperative opioids, with baseline differences noted among cohorts being primarily clinically insignificant. The odds ratio of complications increased even with minimal opioid use, establishing a dose-dependent relationship where higher opioid consumption correlated with increased complications, including a notable risk of prosthetic joint infections. Moreover, significant findings included that patients taking over 10 OMEs daily faced much higher revision rates after surgery.
Despite the alarming insights regarding opioid use, one positive takeaway is the observed increase in opioid-naive patients, indicating improvements in managing opioid prescriptions. In concluding remarks, Spencer emphasizes the need for healthcare providers to consider patients' opioid use prior to surgery and offers a cautious optimism about decreasing opioid dependence in recent years.